SCHEMBL31258625

SCHEMBL31258625

Cn1c(N)nc2cc(Cc3cccnc3)cc(C#N)c21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.40
PGK1 P00558 1/20 0.39
ALDH1A1 P00352 5/20 0.38
HPGD P15428 4/20 0.38
MAPT P10636 1/20 0.38
HIF1A Q16665 1/20 0.38
PPARG P37231 1/20 0.38
NCOA2 Q15596 1/20 0.38
NCOA1 Q15788 1/20 0.38
NCOA3 Q9Y6Q9 1/20 0.38
BACE1 P56817 1/20 0.38
CYP19A1 P11511 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
MKNK1 Q9BUB5 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36
HSD17B10 Q99714 3/20 0.35
KDM4E B2RXH2 2/20 0.35
LMNA P02545 2/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25171841 1.00 TSHR (0.40) TSHRPGK1ALDH1A1HPGDMAPT
SCHEMBL25168462 0.87 LTB4R (0.45) ALDH1A1HPGDMAPTBACE1KDM4E
SCHEMBL31258646 0.87 LTB4R (0.45) ALDH1A1HPGDMAPTBACE1KDM4E
SCHEMBL31258613 0.86 RAB9A (0.36) TSHRALDH1A1MAPTCYP19A1CYP11B1
Hydrochloric Acid SCHEMBL25175077 0.86 LTB4R (0.44) ALDH1A1HPGDMAPTBACE1KDM4E
Hydrochloric Acid SCHEMBL31220087 0.86 LTB4R (0.44) ALDH1A1HPGDMAPTBACE1KDM4E
SCHEMBL25168395 0.86 RAB9A (0.36) TSHRALDH1A1MAPTCYP19A1CYP11B1
SCHEMBL25174942 0.84 CYP19A1 (0.36) TSHRALDH1A1NCOA3BACE1CYP19A1
SCHEMBL34467010 0.84 CYP19A1 (0.36) TSHRALDH1A1NCOA3BACE1CYP19A1
SCHEMBL25175036 0.83 BACE1 (0.40) MAPTBACE1CYP19A1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260109709-A1 2-AMINO IMIDAZOLE DERIVATIVES AS PRMT5 INHIBITORS MIRATI THERAPEUTICS INC (US) 2026-04-23 US claimed
CN-118974035-A 2-Aminoimidazole derivatives as PRMT5 inhibitors 米拉蒂医疗股份有限公司 2024-11-15 CN claimed
US-20260109709-A1 2-AMINO IMIDAZOLE DERIVATIVES AS PRMT5 INHIBITORS MIRATI THERAPEUTICS INC (US) 2026-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260109709-A1 2-AMINO IMIDAZOLE DERIVATIVES AS PRMT5 INHIBITORS PRMT5, PRMT1, PRMT3 TSHR 1646/4885PGK1 2727/4885ALDH1A1 4159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.